{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:33:13Z","timestamp":1761294793375,"version":"3.28.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,26]]},"DOI":"10.7759\/cureus.72425","type":"journal-article","created":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T15:10:42Z","timestamp":1729955442000},"source":"Crossref","is-referenced-by-count":1,"title":["Extensive Deep Vein Thrombosis and Pulmonary Embolism in a Young Patient With Heterozygous Factor V Leiden Mutation and Antiphospholipid Syndrome"],"prefix":"10.7759","author":[{"given":"Elena  A","family":"Sava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu I","family":"S\u00e2ntean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Manea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoleta M","family":"Cr\u0103ciun-Ciorba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31823a088c","article-title":"Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited","volume":"114","author":"Wolberg AS","year":"2012","unstructured":"Wolberg AS, Aleman MM, Leiderman K, Machlus KR. Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited. Anesth Analg. 2012, 114:275-85. 10.1213\/ANE.0b013e31823a088c","journal-title":"Anesth Analg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0065-2423(09)49006-1","article-title":"Factor V Leiden and activated protein C resistance","volume":"49","author":"Segers O","year":"2009","unstructured":"Segers O, Castoldi E. Factor V Leiden and activated protein C resistance. Adv Clin Chem. 2009, 49:121-57. 10.1016\/s0065-2423(09)49006-1","journal-title":"Adv Clin Chem"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2020.04.006","article-title":"Antiphospholipid syndrome","volume":"225","author":"Petri M","year":"2020","unstructured":"Petri M. Antiphospholipid syndrome. Transl Res. 2020, 225:70-81. 10.1016\/j.trsl.2020.04.006","journal-title":"Transl Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14740\/jmc3914","article-title":"Homozygous Factor V Leiden complicated by heparin-induced thrombocytopenia: a case report","volume":"13","author":"Bautista Sanchez R","year":"2022","unstructured":"Bautista Sanchez R, Gely Y, Iglesias JN. Homozygous Factor V Leiden complicated by heparin-induced thrombocytopenia: a case report. J Med Cases. 2022, 13:225-8. 10.14740\/jmc3914","journal-title":"J Med Cases"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es N","year":"2014","unstructured":"van Es N, Coppens M, Schulman S, Middeldorp S, B\u00fcller HR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. 2014, 124:1968-75. 10.1182\/blood-2014-04-571232","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-021-00302-w","article-title":"Lead thrombus under standard-dose edoxaban in a patient with normal to high creatinine clearance and protein S deficiency","volume":"19","author":"Lee WC","year":"2021","unstructured":"Lee WC, Huang MP. Lead thrombus under standard-dose edoxaban in a patient with normal to high creatinine clearance and protein S deficiency. Thromb J. 2021, 19:50. 10.1186\/s12959-021-00302-w","journal-title":"Thromb J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2152\/jmi.66.182","article-title":"Recurrent venous thrombosis during direct oral anticoagulant therapy in a patient with protein S deficiency","volume":"66","author":"Yagi S","year":"2019","unstructured":"Yagi S, Kagawa K, Fujimoto E, Sata M. Recurrent venous thrombosis during direct oral anticoagulant therapy in a patient with protein S deficiency. J Med Invest. 2019, 66:182-4. 10.2152\/jmi.66.182","journal-title":"J Med Invest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202101_24402","article-title":"Clinical characteristics, genes identification and follow-up study of a patient with central venous thrombosis from a protein S deficiency pedigree","volume":"25","author":"Wang T","year":"2021","unstructured":"Wang T, Zhao XJ, Zhu HD, Lu M, Wen B, Ma L. Clinical characteristics, genes identification and follow-up study of a patient with central venous thrombosis from a protein S deficiency pedigree. Eur Rev Med Pharmacol Sci. 2021, 25:353-61. 10.26355\/eurrev_202101_24402","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000904","article-title":"An exceptional case of severe combined inherited thrombophilia successfully treated with rivaroxaban","volume":"31","author":"Krumb E","year":"2020","unstructured":"Krumb E, Hermans C. An exceptional case of severe combined inherited thrombophilia successfully treated with rivaroxaban. Blood Coagul Fibrinolysis. 2020, 31:279-82. 10.1097\/MBC.0000000000000904","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025575","article-title":"Multiple arterial and venous thromboembolism in a male patient with hereditary protein C deficiency: a case report","volume":"100","author":"Sun L","year":"2021","unstructured":"Sun L, Li X, Li Q, Wang L, Li J, Shu C. Multiple arterial and venous thromboembolism in a male patient with hereditary protein C deficiency: a case report. Medicine (Baltimore). 2021, 100:e25575. 10.1097\/MD.0000000000025575","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017012047","article-title":"Rivaroxaban dose adjustment using thrombin generation in severe congenital protein C deficiency and warfarin-induced skin necrosis","volume":"2","author":"Menon N","year":"2018","unstructured":"Menon N, Sarode R, Zia A. Rivaroxaban dose adjustment using thrombin generation in severe congenital protein C deficiency and warfarin-induced skin necrosis. Blood Adv. 2018, 2:142-5. 10.1182\/bloodadvances.2017012047","journal-title":"Blood Adv"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105320","article-title":"Recurrent cerebral venous thrombosis treated with direct oral anticoagulants in a Japanese man with hereditary protein C deficiency","volume":"30","author":"Saito K","year":"2021","unstructured":"Saito K, Ishii K, Furuta K, Kobayashi M, Wada Y, Morishita E. Recurrent cerebral venous thrombosis treated with direct oral anticoagulants in a Japanese man with hereditary protein C deficiency. J Stroke Cerebrovasc Dis. 2021, 30:105320. 10.1016\/j.jstrokecerebrovasdis.2020.105320","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27686","article-title":"Management of severe congenital protein C deficiency with a direct oral anticoagulant, edoxaban: a case report","volume":"66","author":"Watanabe K","year":"2019","unstructured":"Watanabe K, Arakawa Y, Yanagi M, Isobe K, Mori M, Koh K. Management of severe congenital protein C deficiency with a direct oral anticoagulant, edoxaban: a case report. Pediatr Blood Cancer. 2019, 66:e27686. 10.1002\/pbc.27686","journal-title":"Pediatr Blood Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jccase.2018.12.007","article-title":"Efficacy and safety of apixaban in a patient with systemic venous thromboembolism associated with hereditary antithrombin deficiency","volume":"19","author":"Nojima Y","year":"2019","unstructured":"Nojima Y, Ihara M, Adachi H, Kurimoto T, Nanto S. Efficacy and safety of apixaban in a patient with systemic venous thromboembolism associated with hereditary antithrombin deficiency. J Cardiol Cases. 2019, 19:106-9. 10.1016\/j.jccase.2018.12.007","journal-title":"J Cardiol Cases"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0483-17","article-title":"Efficacy of oral factor Xa inhibitor for venous thromboembolism in a patient with antithrombin deficiency","volume":"57","author":"Minami K","year":"2018","unstructured":"Minami K, Kumagai K, Sugai Y, Nakamura K, Naito S, Oshima S. Efficacy of oral factor Xa inhibitor for venous thromboembolism in a patient with antithrombin deficiency. Intern Med. 2018, 57:2025-8. 10.2169\/internalmedicine.0483-17","journal-title":"Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014533304","article-title":"Rivaroxaban for the long-term treatment of spontaneous ovarian vein thrombosis caused by factor V Leiden homozygosity","volume":"48","author":"Cook RM","year":"2014","unstructured":"Cook RM, Rondina MT, Horton DJ. Rivaroxaban for the long-term treatment of spontaneous ovarian vein thrombosis caused by factor V Leiden homozygosity. Ann Pharmacother. 2014, 48:1055-60. 10.1177\/1060028014533304","journal-title":"Ann Pharmacother"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11949","article-title":"Anticoagulation therapy in a patient with heterozygous factor V Leiden and coexisting homozygous prothrombin gene mutations","volume":"12","author":"Costa RL","year":"2020","unstructured":"Costa RL, Triggs M, Cole SE, Lacey J, Reddy S. Anticoagulation therapy in a patient with heterozygous factor V Leiden and coexisting homozygous prothrombin gene mutations. Cureus. 2020, 12:e11949. 10.7759\/cureus.11949","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2450\/2020.0091-20","article-title":"Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 Register study","volume":"18","author":"Margaglione M","year":"2020","unstructured":"Margaglione M, Antonucci E, D'Andrea G, et al.. Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 Register study. Blood Transfus. 2020, 18:486-95. 10.2450\/2020.0091-20","journal-title":"Blood Transfus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2019.044","article-title":"Direct oral anticoagulants in patients affected by major congenital thrombophilia","volume":"11","author":"Serrao A","year":"2019","unstructured":"Serrao A, Lucani B, Mansour D, et al.. Direct oral anticoagulants in patients affected by major congenital thrombophilia. Mediterr J Hematol Infect Dis. 2019, 11:e2019044. 10.4084\/MJHID.2019.044","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.715878","article-title":"Use of direct oral anticoagulants in patients with antiphospholipid syndrome: a systematic review and comparison of the international guidelines","volume":"8","author":"Pastori D","year":"2021","unstructured":"Pastori D, Menichelli D, Cammisotto V, Pignatelli P. Use of direct oral anticoagulants in patients with antiphospholipid syndrome: a systematic review and comparison of the international guidelines. Front Cardiovasc Med. 2021, 8:715878. 10.3389\/fcvm.2021.715878","journal-title":"Front Cardiovasc Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/302111-extensive-deep-vein-thrombosis-and-pulmonary-embolism-in-a-young-patient-with-heterozygous-factor-v-leiden-mutation-and-antiphospholipid-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T15:10:44Z","timestamp":1729955444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/302111-extensive-deep-vein-thrombosis-and-pulmonary-embolism-in-a-young-patient-with-heterozygous-factor-v-leiden-mutation-and-antiphospholipid-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.72425","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,26]]}}}